RE: RNS OUT!8 May 2019 09:20
It's the CTX data that will be later due to fuson wanting to trial it in China. Anyway, point is, anybody selling because of that must be unbelievably short sighted and naive. The rns is littered with references to ongoing discussions about licencing deals and further partnerships etc, and we're due news on the 2nd cohort of hRPC in the next couple of weeks, which if positive, will see a significant rerating of share price, mark my words.